More SEC Filings
View Older Stories View Newer Stories-
Form SCHEDULE 13G/A PELOTON INTERACTIVE, Filed by: Nantahala Capital Management, LLC
-
Form SCHEDULE 13G/A Edgewise Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form 425 Essential Utilities, Filed by: Essential Utilities, Inc.
-
Form 424B3 Agassi Sports Entertainm
-
Form SCHEDULE 13G/A GEOSPACE TECHNOLOGIES Filed by: DISCIPLINED GROWTH INVESTORS INC /MN
-
Form 424B3 Cantor Fitzgerald Income
-
Form 424B2 UBS AG
-
Form SCHEDULE 13G/A Karyopharm Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 497K Themes ETF Trust
-
Form SCHEDULE 13G/A Velo3D, Inc. Filed by: AWM Investment Company, Inc.
-
Form 424B2 UBS AG
-
Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: Caligan Partners LP
-
Form 424B2 UBS AG
-
Form 424B2 Jefferies Financial Grou
-
Form N-PX CHICKASAW CAPITAL MANAGE For: Jun 30
-
Form SCHEDULE 13G/A TELA Bio, Inc. Filed by: Nantahala Capital Management, LLC
-
Form SCHEDULE 13G/A CervoMed Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: Nantahala Capital Management, LLC
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form N-PX STANCE CAPITAL LLC For: Jun 30
-
Form D GS Finance Corp.
-
Form 10-K/A Greenland Mines Ltd For: Dec 31
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form SCHEDULE 13G/A C4 Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form 424B2 UBS AG
-
Form SCHEDULE 13G/A BIOCRYST PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 CITIGROUP INC
-
Form 4 Denali Therapeutics Inc. For: Aug 12 Filed by: Watts Ryan J.
-
Form D KDSA Watkins Co-Invest
-
Form 424B2 UBS AG
-
Form D Capital Alliance Private
-
Form 424B2 UBS AG
-
Form SCHEDULE 13G/A Firefly Aerospace Inc. Filed by: AEROEQUITY GP, LLC
-
Form 497K Themes ETF Trust
-
Form 424B2 UBS AG
-
Form D/A PST OZ AG Fund LLC
-
Form SCHEDULE 13G/A Atrium Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: Commodore Capital LP
-
Form 424B2 UBS AG
-
Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form 424B2 UBS AG
-
Form SCHEDULE 13G Globant S.A. Filed by: Alyeska Investment Group, L.P.
-
Form 13F-HR Nicholas Investment Part For: Jun 30
